Science
Mechanism of Action
Resveratryl Triglycolate functions as a prodrug of resveratrol, effectively inhibiting cellular melanin synthesis through a multi-faceted approach. It directly suppresses the catalytic activity of human tyrosinase (TYR) and downregulates the gene expression and maturation of critical melanogenic enzymes, including TYR, tyrosinase-related protein 1, and L-3,4-dihydroxyphenylalanine chrome tautomerase. Furthermore, RTG significantly suppresses microphthalmia-associated transcription factor (MITF), a key regulator of melanogenesis. Beyond pigmentation control, it acts as a potent antioxidant by directly neutralizing reactive oxygen species (ROS) and enhancing intrinsic cellular antioxidant capacity via Nrf2-dependent mechanisms. It also exhibits anti-inflammatory properties by mitigating inflammatory responses. As an anti-aging agent, RTG may inhibit matrix metalloproteinases (MMPs), promote collagen synthesis, and reduce the appearance of wrinkles, with its resveratrol component also protecting keratinocytes from oxidative damage and preventing keratinocyte-induced melanocyte stimulation.
Research
Clinical Evidence
Medium confidence0.4%
Key findings
- 01 In a human clinical study, a 0.4% concentration of Resveratryl Triglycolate, applied twice daily for up to 8 weeks, significantly lightened skin pigmentation in subjects with Fitzpatrick skin types III or IV. This depigmenting effect was quantified by improvements in visual assessment of pigmentation degree, reductions in melanin index, and increases in L* skin lightness values. Crucially, no adverse skin reactions were observed during the study period.
Transparency
Dusting Analysis
Based on available clinical data, Resveratryl Triglycolate has demonstrated efficacy at 0.4%. There is no indication that this ingredient is commonly 'dusted' or used solely for marketing claims below effective concentrations.
The Formula
Formulation
Stability
The optimal pH range for Resveratryl Triglycolate's stability is not explicitly defined. However, considering its parent compound, resveratrol, demonstrates exponentially increased degradation above pH 6.8, formulating in acidic conditions is likely beneficial for maintaining the ingredient's stability and efficacy.
Safety
Safety Profile
A 0.4% concentration of Resveratryl Triglycolate demonstrated no observed adverse skin reactions in human clinical trials. While its parent compound, resveratrol, has been associated with weak irritation at 0.5% in some reports, another similar resveratrol prodrug, Resveratryl Triacetate, caused no irritation at 0.1% or 0.5%. This collective evidence suggests a generally low irritancy profile for Resveratryl Triglycolate.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Resveratryl Triglycolate is a valuable multi-functional ingredient demonstrating proven clinical efficacy in skin lightening and hyperpigmentation reduction, alongside potent antioxidant, anti-inflammatory, and anti-aging benefits for comprehensive skin improvement.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources